PEL cells carry wtp53 and display the constitutive activation of several pro‐survival pathways such as STAT3 and mammalian target of rapamycin (mTOR), whose targeting has been reported to be an effective strategy in reducing PEL cells survival.11, 12, 13. Here, MTOR is linked to primary effusion lymphoma.